カテゴリー： Market Monitor Global, 世界, 医療/バイオ

整形外科用細胞療法の世界市場見通し2023年-2029年

◆英語タイトル：Orthopedic Cell Therapy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5452）

◆商品コード：MMG23JU5452
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：101
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Orthopedic Cell Therapy Market 調査レポートは次の情報を含め、グローバルにおけるの整形外科用細胞療法市場規模と予測を収録しています。・世界の整形外科用細胞療法市場：売上、2018年-2023年、2024年-2029年
・世界の整形外科用細胞療法市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の整形外科用細胞療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「多血小板血漿注射」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

整形外科用細胞療法のグローバル主要企業は、Medtronic、 Genzyme、 DePuy Synthes、 Anika Therapeutics、 Ferring Pharmaceuticals、 Stryker、 NuVasive、 Bioventus、 Zimmer Biomet、 Integra LifeSciences、 RTI Surgical、 Fidia Pharmaceuticals、 MTF、 Orthofix、 Arthrexなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、整形外科用細胞療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の整形外科用細胞療法市場：タイプ別、2018年-2023年、2024年-2029年
世界の整形外科用細胞療法市場：タイプ別市場シェア、2022年
・多血小板血漿注射、骨髄治療、その他

世界の整形外科用細胞療法市場：用途別、2018年-2023年、2024年-2029年
世界の整形外科用細胞療法市場：用途別市場シェア、2022年
・骨折、軟部組織挫傷、変形性関節症、その他

世界の整形外科用細胞療法市場：地域・国別、2018年-2023年、2024年-2029年
世界の整形外科用細胞療法市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における整形外科用細胞療法のグローバル売上、2018年-2023年
・主要企業における整形外科用細胞療法のグローバル売上シェア、2022年
・主要企業における整形外科用細胞療法のグローバル販売量、2018年-2023年
・主要企業における整形外科用細胞療法のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Medtronic、 Genzyme、 DePuy Synthes、 Anika Therapeutics、 Ferring Pharmaceuticals、 Stryker、 NuVasive、 Bioventus、 Zimmer Biomet、 Integra LifeSciences、 RTI Surgical、 Fidia Pharmaceuticals、 MTF、 Orthofix、 Arthrex

*************************************************************

・調査・分析レポートの概要
整形外科用細胞療法市場の定義
市場セグメント
世界の整形外科用細胞療法市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の整形外科用細胞療法市場規模
世界の整形外科用細胞療法市場規模：2022年 VS 2029年
世界の整形外科用細胞療法市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの整形外科用細胞療法の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の整形外科用細胞療法製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：多血小板血漿注射、骨髄治療、その他
整形外科用細胞療法のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：骨折、軟部組織挫傷、変形性関節症、その他
整形外科用細胞療法の用途別グローバル売上・予測

・地域別市場分析
地域別整形外科用細胞療法市場規模 2022年と2029年
地域別整形外科用細胞療法売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、 Genzyme、 DePuy Synthes、 Anika Therapeutics、 Ferring Pharmaceuticals、 Stryker、 NuVasive、 Bioventus、 Zimmer Biomet、 Integra LifeSciences、 RTI Surgical、 Fidia Pharmaceuticals、 MTF、 Orthofix、 Arthrex
...

This report aims to provide a comprehensive presentation of the global market for Orthopedic Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedic Cell Therapy. This report contains market size and forecasts of Orthopedic Cell Therapy in global, including the following market information:
Global Orthopedic Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Orthopedic Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Platelet-rich Plasma Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Orthopedic Cell Therapy include Medtronic, Genzyme, DePuy Synthes, Anika Therapeutics, Ferring Pharmaceuticals, Stryker, NuVasive, Bioventus and Zimmer Biomet, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orthopedic Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orthopedic Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Orthopedic Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Platelet-rich Plasma Injection
Bone Marrow Therapy
Others
Global Orthopedic Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Orthopedic Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Fractures
Soft Tissue Contusions
Osteoarthritis
Others
Global Orthopedic Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Orthopedic Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orthopedic Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Orthopedic Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Genzyme
DePuy Synthes
Anika Therapeutics
Ferring Pharmaceuticals
Stryker
NuVasive
Bioventus
Zimmer Biomet
Integra LifeSciences
RTI Surgical
Fidia Pharmaceuticals
MTF
Orthofix
Arthrex
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orthopedic Cell Therapy, market overview.
Chapter 2: Global Orthopedic Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Orthopedic Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orthopedic Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Orthopedic Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orthopedic Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orthopedic Cell Therapy Overall Market Size
2.1 Global Orthopedic Cell Therapy Market Size: 2022 VS 2029
2.2 Global Orthopedic Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orthopedic Cell Therapy Players in Global Market
3.2 Top Global Orthopedic Cell Therapy Companies Ranked by Revenue
3.3 Global Orthopedic Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Orthopedic Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orthopedic Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthopedic Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Orthopedic Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Orthopedic Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Orthopedic Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 Platelet-rich Plasma Injection
4.1.3 Bone Marrow Therapy
4.1.4 Others
4.2 By Type – Global Orthopedic Cell Therapy Revenue & Forecasts
4.2.1 By Type – Global Orthopedic Cell Therapy Revenue, 2018-2023
4.2.2 By Type – Global Orthopedic Cell Therapy Revenue, 2024-2029
4.2.3 By Type – Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Orthopedic Cell Therapy Market Size, 2022 & 2029
5.1.2 Fractures
5.1.3 Soft Tissue Contusions
5.1.4 Osteoarthritis
5.1.5 Others
5.2 By Application – Global Orthopedic Cell Therapy Revenue & Forecasts
5.2.1 By Application – Global Orthopedic Cell Therapy Revenue, 2018-2023
5.2.2 By Application – Global Orthopedic Cell Therapy Revenue, 2024-2029
5.2.3 By Application – Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Orthopedic Cell Therapy Market Size, 2022 & 2029
6.2 By Region – Global Orthopedic Cell Therapy Revenue & Forecasts
6.2.1 By Region – Global Orthopedic Cell Therapy Revenue, 2018-2023
6.2.2 By Region – Global Orthopedic Cell Therapy Revenue, 2024-2029
6.2.3 By Region – Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Orthopedic Cell Therapy Revenue, 2018-2029
6.3.2 US Orthopedic Cell Therapy Market Size, 2018-2029
6.3.3 Canada Orthopedic Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Orthopedic Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Orthopedic Cell Therapy Revenue, 2018-2029
6.4.2 Germany Orthopedic Cell Therapy Market Size, 2018-2029
6.4.3 France Orthopedic Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Orthopedic Cell Therapy Market Size, 2018-2029
6.4.5 Italy Orthopedic Cell Therapy Market Size, 2018-2029
6.4.6 Russia Orthopedic Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Orthopedic Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Orthopedic Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Orthopedic Cell Therapy Revenue, 2018-2029
6.5.2 China Orthopedic Cell Therapy Market Size, 2018-2029
6.5.3 Japan Orthopedic Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Orthopedic Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Orthopedic Cell Therapy Market Size, 2018-2029
6.5.6 India Orthopedic Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Orthopedic Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Orthopedic Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Orthopedic Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Orthopedic Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Orthopedic Cell Therapy Market Size, 2018-2029
6.7.3 Israel Orthopedic Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Orthopedic Cell Therapy Market Size, 2018-2029
6.7.5 UAE Orthopedic Cell Therapy Market Size, 2018-2029
7 Orthopedic Cell Therapy Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Orthopedic Cell Therapy Major Product Offerings
7.1.4 Medtronic Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Genzyme
7.2.1 Genzyme Company Summary
7.2.2 Genzyme Business Overview
7.2.3 Genzyme Orthopedic Cell Therapy Major Product Offerings
7.2.4 Genzyme Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Genzyme Key News & Latest Developments
7.3 DePuy Synthes
7.3.1 DePuy Synthes Company Summary
7.3.2 DePuy Synthes Business Overview
7.3.3 DePuy Synthes Orthopedic Cell Therapy Major Product Offerings
7.3.4 DePuy Synthes Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 DePuy Synthes Key News & Latest Developments
7.4 Anika Therapeutics
7.4.1 Anika Therapeutics Company Summary
7.4.2 Anika Therapeutics Business Overview
7.4.3 Anika Therapeutics Orthopedic Cell Therapy Major Product Offerings
7.4.4 Anika Therapeutics Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Anika Therapeutics Key News & Latest Developments
7.5 Ferring Pharmaceuticals
7.5.1 Ferring Pharmaceuticals Company Summary
7.5.2 Ferring Pharmaceuticals Business Overview
7.5.3 Ferring Pharmaceuticals Orthopedic Cell Therapy Major Product Offerings
7.5.4 Ferring Pharmaceuticals Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Ferring Pharmaceuticals Key News & Latest Developments
7.6 Stryker
7.6.1 Stryker Company Summary
7.6.2 Stryker Business Overview
7.6.3 Stryker Orthopedic Cell Therapy Major Product Offerings
7.6.4 Stryker Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Stryker Key News & Latest Developments
7.7 NuVasive
7.7.1 NuVasive Company Summary
7.7.2 NuVasive Business Overview
7.7.3 NuVasive Orthopedic Cell Therapy Major Product Offerings
7.7.4 NuVasive Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 NuVasive Key News & Latest Developments
7.8 Bioventus
7.8.1 Bioventus Company Summary
7.8.2 Bioventus Business Overview
7.8.3 Bioventus Orthopedic Cell Therapy Major Product Offerings
7.8.4 Bioventus Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Bioventus Key News & Latest Developments
7.9 Zimmer Biomet
7.9.1 Zimmer Biomet Company Summary
7.9.2 Zimmer Biomet Business Overview
7.9.3 Zimmer Biomet Orthopedic Cell Therapy Major Product Offerings
7.9.4 Zimmer Biomet Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Zimmer Biomet Key News & Latest Developments
7.10 Integra LifeSciences
7.10.1 Integra LifeSciences Company Summary
7.10.2 Integra LifeSciences Business Overview
7.10.3 Integra LifeSciences Orthopedic Cell Therapy Major Product Offerings
7.10.4 Integra LifeSciences Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Integra LifeSciences Key News & Latest Developments
7.11 RTI Surgical
7.11.1 RTI Surgical Company Summary
7.11.2 RTI Surgical Business Overview
7.11.3 RTI Surgical Orthopedic Cell Therapy Major Product Offerings
7.11.4 RTI Surgical Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 RTI Surgical Key News & Latest Developments
7.12 Fidia Pharmaceuticals
7.12.1 Fidia Pharmaceuticals Company Summary
7.12.2 Fidia Pharmaceuticals Business Overview
7.12.3 Fidia Pharmaceuticals Orthopedic Cell Therapy Major Product Offerings
7.12.4 Fidia Pharmaceuticals Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Fidia Pharmaceuticals Key News & Latest Developments
7.13 MTF
7.13.1 MTF Company Summary
7.13.2 MTF Business Overview
7.13.3 MTF Orthopedic Cell Therapy Major Product Offerings
7.13.4 MTF Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 MTF Key News & Latest Developments
7.14 Orthofix
7.14.1 Orthofix Company Summary
7.14.2 Orthofix Business Overview
7.14.3 Orthofix Orthopedic Cell Therapy Major Product Offerings
7.14.4 Orthofix Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Orthofix Key News & Latest Developments
7.15 Arthrex
7.15.1 Arthrex Company Summary
7.15.2 Arthrex Business Overview
7.15.3 Arthrex Orthopedic Cell Therapy Major Product Offerings
7.15.4 Arthrex Orthopedic Cell Therapy Revenue in Global Market (2018-2023)
7.15.5 Arthrex Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Orthopedic Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Orthopedic Cell Therapy Market Drivers in Global Market
Table 3. Orthopedic Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Orthopedic Cell Therapy in Global Market
Table 5. Top Orthopedic Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Orthopedic Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Orthopedic Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Orthopedic Cell Therapy Product Type
Table 9. List of Global Tier 1 Orthopedic Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orthopedic Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Orthopedic Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Orthopedic Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Orthopedic Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Orthopedic Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Orthopedic Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Orthopedic Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Orthopedic Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Orthopedic Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Orthopedic Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Orthopedic Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Orthopedic Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Orthopedic Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Orthopedic Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Orthopedic Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Medtronic Company Summary
Table 31. Medtronic Orthopedic Cell Therapy Product Offerings
Table 32. Medtronic Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Medtronic Key News & Latest Developments
Table 34. Genzyme Company Summary
Table 35. Genzyme Orthopedic Cell Therapy Product Offerings
Table 36. Genzyme Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Genzyme Key News & Latest Developments
Table 38. DePuy Synthes Company Summary
Table 39. DePuy Synthes Orthopedic Cell Therapy Product Offerings
Table 40. DePuy Synthes Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. DePuy Synthes Key News & Latest Developments
Table 42. Anika Therapeutics Company Summary
Table 43. Anika Therapeutics Orthopedic Cell Therapy Product Offerings
Table 44. Anika Therapeutics Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Anika Therapeutics Key News & Latest Developments
Table 46. Ferring Pharmaceuticals Company Summary
Table 47. Ferring Pharmaceuticals Orthopedic Cell Therapy Product Offerings
Table 48. Ferring Pharmaceuticals Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Ferring Pharmaceuticals Key News & Latest Developments
Table 50. Stryker Company Summary
Table 51. Stryker Orthopedic Cell Therapy Product Offerings
Table 52. Stryker Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Stryker Key News & Latest Developments
Table 54. NuVasive Company Summary
Table 55. NuVasive Orthopedic Cell Therapy Product Offerings
Table 56. NuVasive Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. NuVasive Key News & Latest Developments
Table 58. Bioventus Company Summary
Table 59. Bioventus Orthopedic Cell Therapy Product Offerings
Table 60. Bioventus Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Bioventus Key News & Latest Developments
Table 62. Zimmer Biomet Company Summary
Table 63. Zimmer Biomet Orthopedic Cell Therapy Product Offerings
Table 64. Zimmer Biomet Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Zimmer Biomet Key News & Latest Developments
Table 66. Integra LifeSciences Company Summary
Table 67. Integra LifeSciences Orthopedic Cell Therapy Product Offerings
Table 68. Integra LifeSciences Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Integra LifeSciences Key News & Latest Developments
Table 70. RTI Surgical Company Summary
Table 71. RTI Surgical Orthopedic Cell Therapy Product Offerings
Table 72. RTI Surgical Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. RTI Surgical Key News & Latest Developments
Table 74. Fidia Pharmaceuticals Company Summary
Table 75. Fidia Pharmaceuticals Orthopedic Cell Therapy Product Offerings
Table 76. Fidia Pharmaceuticals Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Fidia Pharmaceuticals Key News & Latest Developments
Table 78. MTF Company Summary
Table 79. MTF Orthopedic Cell Therapy Product Offerings
Table 80. MTF Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. MTF Key News & Latest Developments
Table 82. Orthofix Company Summary
Table 83. Orthofix Orthopedic Cell Therapy Product Offerings
Table 84. Orthofix Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Orthofix Key News & Latest Developments
Table 86. Arthrex Company Summary
Table 87. Arthrex Orthopedic Cell Therapy Product Offerings
Table 88. Arthrex Orthopedic Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Arthrex Key News & Latest Developments
List of Figures
Figure 1. Orthopedic Cell Therapy Segment by Type in 2022
Figure 2. Orthopedic Cell Therapy Segment by Application in 2022
Figure 3. Global Orthopedic Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Orthopedic Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Orthopedic Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orthopedic Cell Therapy Revenue in 2022
Figure 8. By Type - Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Orthopedic Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Orthopedic Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Orthopedic Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Orthopedic Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Medtronic Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Genzyme Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. DePuy Synthes Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Anika Therapeutics Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Ferring Pharmaceuticals Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Stryker Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NuVasive Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bioventus Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Zimmer Biomet Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Integra LifeSciences Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. RTI Surgical Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Fidia Pharmaceuticals Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. MTF Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Orthofix Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Arthrex Orthopedic Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 整形外科用細胞療法の世界市場見通し2023年-2029年(Orthopedic Cell Therapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

整形外科用細胞療法の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp